Marijuana use in acute coronary syndromes

References

• NIH, National Institute on Drug Abuse. Monitoring the Future results, Trends in Prevalence of Various Drugs. 2016.
   Google Scholar
• UNODC, The United Nations Office on Drugs and Crime. World Drug Report. 2012:[112 p.].
   Google Scholar
• UNODC, The United Nations Office on Drugs and Crime. World Drug Report Cannabis Overview. 2014:[41 p.].
   Google Scholar
• Sweetman S. Cannabidiol, dronabinol, nabilone, 35th edn. Nabiximols: Pharmaceutical Press; 2007.
   Google Scholar
• Nahas GG. Effects of hashish consumption in Egypt. N Eng J Med 1972;287:310.
   PubMed Web of Science ®Google Scholar
• Abbas RA, Hammam RA, El-Gohary SS, Sabik LM, Hunter MS. Screening for common mental disorders and substance abuse among temporary hired cleaners in Egyptian Governmental Hospitals, Zagazig City, Sharqia Governorate. Int J Occup Environ Med 2013;4:13–26.
   PubMedGoogle Scholar
• Amr M, El-Gilany AH, El-Mogy A, Fathi w. Substance abuse and dependence among patients attending an emergency hospital in eastern Nile delta, Egypt. J Psychiatry 2014;17:532–537.
   Google Scholar
• Ghanem AA, Hazem M, Mandour RA. Drug and substance abuse in refractory epilepsy. Egypt J Neurol Psychiatry Neurosurg 2008;45:387–394.
   Google Scholar
• Hamdi E, Gawad T, Khoweiled A, Sidrak AE, Amer D, Mamdouh R, et al. Lifetime prevalence of alcohol and substance use in Egypt: a community survey. Subst Abuse 2013;34:97–104. Epub 2013/04/13.
   PubMed Web of Science ®Google Scholar
• El Gohary M, El Kelany R, Oreby M, Lashin H. Study of the prevalence of some of abuse of some substances among some injured patients admitted to Tanta University Emergency Hospital. Ain Shams J Forensic Med Clin Toxicol 2012;18:45–50.
   Google Scholar
• Steg PG, James SK, Atar D, Badano LP, Blömstrom Lundqvist C, Borger MA, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST segment elevation. Eur Heart J 2012;33:2569–2619.
   PubMed Web of Science ®Google Scholar
• Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ 2006;333:1091. Epub 2006/10/13.
   PubMed Web of Science ®Google Scholar
• Ashton CH. Pharmacology and effects of cannabis: a brief review. Br J Psychiatry J Mental Sci 2001;178:101–106.
   PubMed Web of Science ®Google Scholar
• Jones RT. Cardiovascular system effects of marijuana. J Clin Pharmacol 2002;42:58S–63S.
   PubMed Web of Science ®Google Scholar
• Reece AS. Chronic toxicology of cannabis. Clin Toxicol 2009;47:517–524. Epub 2009/07/10.
   PubMed Web of Science ®Google Scholar
• Winstock AR, Ford Ca, Witton J. Assessment and management of cannabis use disorders in primary care. BMJ 2010;340:1571. PubMed.
   PubMed Web of Science ®Google Scholar
• Nawrot TS, Perez L, Künzli N, Munters E, Nemery B. Public health importance of triggers of myocardial infarction: a comparative risk assessment. Lancet 2011;377:732–740.
   PubMed Web of Science ®Google Scholar
• Jouanjus E, Lapeyre-Mestre M, Micallef J. Cannabis use: signal of increasing risk of serious cardiovascular disorders. J Am Heart Assoc. 2014;3:e000638.
   PubMed Web of Science ®Google Scholar
• Abdo HS, Mark FN. Cardiac arrest following cannabis use: a case report. Cases J 2009;2:208.
   PubMedGoogle Scholar
• Hancock-Allen JB, Barker L, VanDyke M, Holmes DB. Notes from the Field: Death Following Ingestion of an Edible Marijuana Product - Colorado, March 2014. Weekly. 2015;64:771–772.
   Google Scholar
• Ibrahim S, Al-Saffar F, Wannenburg T. Case report, a unique case of cardiac Arrest following K2 Abuse. Case Rep Cardiol 2014;2014:3.
   Google Scholar
• Winkel BG, Holst AG, Theilade J, Kristensen IB, Thomsen JL, Ottesen GL, et al. Nationwide study of sudden cardiac death in persons aged 1–35 years. Eur Heart J 2011;32:983–990. Epub 2010/12/07.
   PubMed Web of Science ®Google Scholar
• Wagner A, Arveiler D, Ruidavets JB, Bingham A, Montaye M, Ferrieres J, et al. Gender- and age-specific trends in coronary heart disease mortality in France from 2000 to 2007: results from the MONICA registers. Eur J Prev Cardiol 2014;21:117–122. Epub 2012/06/22.
   PubMed Web of Science ®Google Scholar
• Mallaina P, Lionis C, Rol H., Imperiali R, Burgess A, Nixon M, et al. Smoking cessation and the risk of cardiovascular disease outcomes predicted from established risk scores: results of the Cardiovascular Risk Assessment among Smokers in Primary Care in Europe (CV‐ASPIRE) Study. BMC Publ Health 2013;13:362. PubMed.
   Google Scholar
• Stevens J, Erber E, Truesdale KP, Wang CH, Cai J. Long- and short-term weight change and incident coronary heart disease and ischemic stroke: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 2013;178:239–248. Epub 2013/05/07.
   PubMed Web of Science ®Google Scholar
• Wall ME, Sadler BM, Brine D, Taylor H, Perez-Reyes M. Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women. Clin Pharmacol Ther 1983;34:352–363. Epub 1983/09/01.
   PubMed Web of Science ®Google Scholar
• Dantas FG. Epilepsy and marijuana, a review. J Epilepsy Clin Neurophysiol 2005;11:91–93.
   Google Scholar
• Bilbault P, Corina M, Duja Y, Bornemann, Claire K, Gerald R., et al. Chest pain in young people: Is cannabis a risk factor? J Emerg Trauma Shock. 2010;3:307.
   PubMedGoogle Scholar
• Bélanger RE, Akre C, Kuntsche E, Gmel G, Suris JC. Adding tobacco to cannabis–its frequency and likely implications. Nicotine Tob Res 2011;13:746–750.
   PubMed Web of Science ®Google Scholar
• Beakley BD, Kaye AM, Kaye AD. Tramadol, pharmacology, side effects, and serotonin syndrome: a review. Pain Phys 2015;18:395–400. Epub 2015/07/29.
   Web of Science ®Google Scholar
• Cho HC, Sohn JT, Park KE, Shin IW, Chang KC, Lee JW, et al. Inhibitory effect of tramadol on vasorelaxation mediated by ATP-sensitive K+ channels in rat aorta. Can J Anaesth 2007;54:453–460. Epub 2007/06/02.
   PubMed Web of Science ®Google Scholar
• Westover AN, McBride S, Haley RW. Stroke in young adults who abuse amphetamines or cocaine: a population-based study of hospitalized patients. Arch Gen Psychiatry 2007;64:495–502. Epub 2007/04/04.
   PubMed Web of Science ®Google Scholar
• Weissman NJ, Ristow B, Schiller NB. Role of echocardiography in acute myocardial infarction. UpToDate [Internet]. 2016.
   Google Scholar
• Cappelli F, Lazzeri C, Gensini GF, Valente S. Cannabis: a trigger for acute myocardial infarction? A case report. J Cardiovasc Med 2008;9:725–728.
   Google Scholar
• Velibey Y, Sahin S, Tanık O, Keskin M, Bolca O, Eren M. Acute myocardial infarction due to marijuana smoking in a young man: guilty should not be underestimated. Am J Emerg Med 2015;33:1114.e1–e3. Epub 2015 Jan 23.
   PubMed Web of Science ®Google Scholar
• Mir A, Adebisi O, Amy Y, Band Colin K. Myocardial infarction associated with use of the synthetic cannabinoid K2. Pediatrics 2011;128:1–6.
   PubMed Web of Science ®Google Scholar
• Casier I, Vanduynhoven P, Haine S, Vrints C, Jorens PG. Is recent cannabis use associated with acute coronary syndromes? An illustrative case series. Acta Cardiol 2014;69:131–136.
   PubMed Web of Science ®Google Scholar
• Thomas G, Kloner RA, Rezkalla S. Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know. Am J Cardiol 2014;113:187–190.
   PubMed Web of Science ®Google Scholar
• Mittleman MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by marijuana. Circulation 2001;103:2805–2809. Epub 2001/06/13.
   PubMed Web of Science ®Google Scholar
• Sidney S. Cardiovascular consequences of marijuana use. J Clin Pharmacol 2002;42:64S–70S.
   PubMed Web of Science ®Google Scholar
• Hollister LE. Health aspects of cannabis. Pharmacol Rev 1986;38:1–20.
   PubMed Web of Science ®Google Scholar
• Sarafian TA, Magallanes JA, Shau H, Tashkin D, Roth MD. Oxidative stress produced by marijuana smoke: An adverse effect enhanced by cannabinoids. Am J Respir Cell Mol Biol 1999;20:1286–1293.
   PubMed Web of Science ®Google Scholar
• Aryana W. Marijuana as a trigger of cardiovascular events: Speculation or scientific certainty? Int J Cardiol 2007;118:141–144.
   PubMed Web of Science ®Google Scholar
• Rodondi N, Pletcher MJ, Liu K, Hulley SB, Sidney S, Coronary Artery Risk Development in Young Adults (CARDIA) Study. Marijuana use, diet, body mass index, and cardiovascular risk factors (from the CARDIA study). Am J Cardiol 2006;98:478–484.
   Google Scholar
• Daldrup T. Cannabis im StraX enverkehr; r Wirtschaft Mittelstand: Technologie und Verkehr NRW; 1996.
   Google Scholar
• Drasch G, von Meyer L, Roider G, et al. Absolute Fahruntu¨ chtigkeit unter der Wirkung von Cannabis-Vorschlag fu¨ einen Grenzwert Blutalkohol 2003;40:269–286.
   Google Scholar